CortexID software option for AW workstation is used to display and analyze PET neurology images acquired on a dedicated PET or hybrid PET/CT scanner.
CortexID is designed to help clinicians quantify pathologies detected with PET and PET-CT brain scans. The software aids in the assessment of human brain scans by providing automated analysis through quantification of the comparison of local peak activity values, at standardized anatomical locations, with the corresponding reference normal peak activity in age- stratified control subjects. The resulting quantification is presented through 3D Stereotactic Surface Projection maps of the brain. CortexID lets the user generate information on the relative changes in metabolic activity between a subject's images and age-stratified controls measured by FDG PET. These relative changes could be the result of brain function alterations by neurodegenerative processes.
CT Fusion to PET offers visualization of structural abnormalities, such as subdural hematoma, tumor, stroke, or cerebrovascular disease, which may result from brain injury, trauma, disorder, disease or dysfunction. CortexID may help clinicians rule out certain processes.